BRAVACCINI, SARA
BRAVACCINI, SARA
ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
2020 Ravaioli, Sara; Tebaldi, Michela; Fonzi, Eugenio; Angeli, Davide; Mazza, Massimiliano; Nicolini, Fabio; Lucchesi, Alessandro; Fanini, Francesca; Pirini, Francesca; Tumedei, Maria Maddalena; Cerchione, Claudio; Viale, Pierluigi; Sambri, Vittorio; Martinelli, Giovanni; Bravaccini, Sara
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy
2024 Roberta Maltoni; Andrea Roncadori; William Balzi; Massimiliano Mazza; Fabio Nicolini; Michela Palleschi; Paola Ulivi; Sara Bravaccini
Are BMI and Negative Hormone Receptors Prognostic Factors in HER2+ Early-stage Breast Cancer?
2020 Maltoni R.; Palleschi M.; Altini M.; Massa I.; Balzi W.; Ravaioli S.; Tumedei M.M.; Rocca A.; Bravaccini S.
Are there differences in androgen receptor expression in invasive breast cancer in African (Tanzanian) population in comparison with the Caucasian (Italian) population?
2018 Bravaccini S.; Ravaioli S.; Amadori D.; Scarpi E.; Puccetti M.; Rocca A.; Tumedei M.M.; Masalu N.; Kahima J.; Pangan A.; Faustine L.; Farolfi A.; Maltoni R.; Bonafe M.; Serra P.; Bronte G.
Are we ready to use TMB in breast cancer clinical practice?
2020 Ravaioli S.; Limarzi F.; Tumedei M.M.; Palleschi M.; Maltoni R.; Bravaccini S.
Atezolizumab plus Nab-paclitaxel in PD-L1–Positive TNBC—Letter
2020 Bravaccini S.; Ravaioli S.; Tumedei M.M.; Rocca A.; Palleschi M.; Puccetti M.; Parrella P.; Altini M.; Maltoni R.
Cancer region detection by visual features in histopathology
2012 A. Bevilacqua; A. Gherardi; C. Busa; S. Bravaccini
Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer
2020 Maltoni R.; Palleschi M.; Ravaioli S.; Tumedei M.M.; Rocca A.; Melegari E.; Altini M.; Puccetti M.; Manunta S.; Bravaccini S.
Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon
2022 Martino, Massimo; Naso, Virginia; Loteta, Barbara; Canale, Filippo Antonio; Pugliese, Marta; Alati, Caterina; Musuraca, Gerardo; Nappi, Davide; Gaimari, Anna; Nicolini, Fabio; Mazza, Massimiliano; Bravaccini, Sara; Derudas, Daniele; Martinelli, Giovanni; Cerchione, Claudio
Combining preclinical tools and models to unravel tumor complexity: Jump into the next dimension
2023 Miserocchi G.; Bocchini M.; Cortesi M.; Arienti C.; De Vita A.; Liverani C.; Mercatali L.; Bravaccini S.; Ulivi P.; Zanoni M.
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival
2023 Tumedei, Maria Maddalena; Piccinini, Filippo; Azzali, Irene; Pirini, Francesca; Bravaccini, Sara; De Matteis, Serena; Agostinelli, Claudio; Castellani, Gastone; Zanoni, Michele; Cortesi, Michela; Vergani, Barbara; Leone, Biagio Eugenio; Righi, Simona; Gazzola, Anna; Casadei, Beatrice; Gentilini, Davide; Calzari, Luciano; Limarzi, Francesco; Sabattini, Elena; Pession, Andrea; Tazzari, Marcella; Bertuzzi, Clara
Immunotherapy: The end of the "dark age" for metastatic triple-negative breast cancer?
2020 Palleschi M.; Maltoni R.; Sarti S.; Melegari E.; Bravaccini S.; Rocca A.
Ki67 and PR in patients treated with CDK4/6 Inhibitors: A real-world experience
2020 Palleschi M.; Maltoni R.; Ravaioli S.; Vagheggini A.; Mannozzi F.; Fanini F.; Pirini F.; Tumedei M.M.; Barzotti E.; Cecconetto L.; Sarti S.; Manunta S.; Possanzini P.; Fedeli A.; Curcio A.; Altini M.; de Giorgi U.; Rocca A.; Bravaccini S.
NMR-Based Metabolomic Approach Tracks Potential Serum Biomarkers of Disease Progression in Patients with Type 2 Diabetes Mellitus
2019 Del Coco, Laura; Vergara, Daniele; De Matteis, Serena; Mensà, Emanuela; Sabbatinelli, Jacopo; Prattichizzo, Francesco; Bonfigli, Anna Rita; Storci, Gianluca; Bravaccini, Sara; Pirini, Francesca; Ragusa, Andrea; Casadei-Gardini, Andrea; Bonafè, Massimiliano; Maffia, Michele; Fanizzi, Francesco Paolo; Olivieri, Fabiola; Giudetti, Anna Maria
Palbociclib (PD 0332991): Targeting the cell cycle machinery in breast cancer
2014 Rocca A.; Farolfi A.; Bravaccini S.; Schirone A.; Amadori D.
Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy
2015 Rocca A.; Andreis D.; Fedeli A.; Maltoni R.; Sarti S.; Cecconetto L.; Pietri E.; Schirone A.; Bravaccini S.; Serra P.; Farolfi A.; Amadori D.
Progress with palbociclib in breast cancer: Latest evidence and clinical considerations
2017 Rocca A.; Schirone A.; Maltoni R.; Bravaccini S.; Cecconetto L.; Farolfi A.; Bronte G.; Andreis D.
PSMA expression: A potential ally for the pathologist in prostate cancer diagnosis
2018 Bravaccini S.; Puccetti M.; Bocchini M.; Ravaioli S.; Celli M.; Scarpi E.; De Giorgi U.; Tumedei M.M.; Raulli G.; Cardinale L.; Paganelli G.
Sorafenib for the treatment of breast cancer
2017 Bronte G.; Andreis D.; Bravaccini S.; Maltoni R.; Cecconetto L.; Schirone A.; Farolfi A.; Fedeli A.; Serra P.; Donati C.; Amadori D.; Rocca A.
T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer
2022 Mazzotti, Lucia; Gaimari, Anna; Bravaccini, Sara; Maltoni, Roberta; Cerchione, Claudio; Juan, Manel; Navarro, Europa Azucena-Gonzalez; Pasetto, Anna; Nascimento Silva, Daniela; Ancarani, Valentina; Sambri, Vittorio; Calabrò, Luana; Martinelli, Giovanni; Mazza, Massimiliano
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients | Ravaioli, Sara; Tebaldi, Michela; Fonzi, Eugenio; Angeli, Davide; Mazza, Massimiliano; Nicolini, ...Fabio; Lucchesi, Alessandro; Fanini, Francesca; Pirini, Francesca; Tumedei, Maria Maddalena; Cerchione, Claudio; Viale, Pierluigi; Sambri, Vittorio; Martinelli, Giovanni; Bravaccini, Sara | 2020-01-01 | CELL TRANSPLANTATION | - | 1.01 Articolo in rivista | 0963689720968749.pdf |
| An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy | Roberta Maltoni; Andrea Roncadori; William Balzi; Massimiliano Mazza; Fabio Nicolini; Michela Pal...leschi; Paola Ulivi; Sara Bravaccini | 2024-01-01 | BIOMEDICINES | - | 1.01 Articolo in rivista | biomedicines-12-00498-v2.pdf |
| Are BMI and Negative Hormone Receptors Prognostic Factors in HER2+ Early-stage Breast Cancer? | Maltoni R.; Palleschi M.; Altini M.; Massa I.; Balzi W.; Ravaioli S.; Tumedei M.M.; Rocca A.; Bra...vaccini S. | 2020-01-01 | CLINICAL BREAST CANCER | - | 1.04 Replica / breve intervento (e simili) | - |
| Are there differences in androgen receptor expression in invasive breast cancer in African (Tanzanian) population in comparison with the Caucasian (Italian) population? | Bravaccini S.; Ravaioli S.; Amadori D.; Scarpi E.; Puccetti M.; Rocca A.; Tumedei M.M.; Masalu N....; Kahima J.; Pangan A.; Faustine L.; Farolfi A.; Maltoni R.; Bonafe M.; Serra P.; Bronte G. | 2018-01-01 | FRONTIERS IN ENDOCRINOLOGY | - | 1.01 Articolo in rivista | - |
| Are we ready to use TMB in breast cancer clinical practice? | Ravaioli S.; Limarzi F.; Tumedei M.M.; Palleschi M.; Maltoni R.; Bravaccini S. | 2020-01-01 | CANCER IMMUNOLOGY, IMMUNOTHERAPY | - | 1.04 Replica / breve intervento (e simili) | - |
| Atezolizumab plus Nab-paclitaxel in PD-L1–Positive TNBC—Letter | Bravaccini S.; Ravaioli S.; Tumedei M.M.; Rocca A.; Palleschi M.; Puccetti M.; Parrella P.; Altin...i M.; Maltoni R. | 2020-01-01 | CLINICAL CANCER RESEARCH | - | 1.04 Replica / breve intervento (e simili) | - |
| Cancer region detection by visual features in histopathology | A. Bevilacqua; A. Gherardi; C. Busa; S. Bravaccini | 2012-01-01 | - | - | 4.03 Poster | - |
| Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer | Maltoni R.; Palleschi M.; Ravaioli S.; Tumedei M.M.; Rocca A.; Melegari E.; Altini M.; Puccetti M....; Manunta S.; Bravaccini S. | 2020-01-01 | CELL TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon | Martino, Massimo; Naso, Virginia; Loteta, Barbara; Canale, Filippo Antonio; Pugliese, Marta; Alat...i, Caterina; Musuraca, Gerardo; Nappi, Davide; Gaimari, Anna; Nicolini, Fabio; Mazza, Massimiliano; Bravaccini, Sara; Derudas, Daniele; Martinelli, Giovanni; Cerchione, Claudio | 2022-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | ijms-23-13332.pdf |
| Combining preclinical tools and models to unravel tumor complexity: Jump into the next dimension | Miserocchi G.; Bocchini M.; Cortesi M.; Arienti C.; De Vita A.; Liverani C.; Mercatali L.; Bravac...cini S.; Ulivi P.; Zanoni M. | 2023-01-01 | FRONTIERS IN IMMUNOLOGY | - | 1.01 Articolo in rivista | fimmu-14-1171141.pdf |
| Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival | Tumedei, Maria Maddalena; Piccinini, Filippo; Azzali, Irene; Pirini, Francesca; Bravaccini, Sara;... De Matteis, Serena; Agostinelli, Claudio; Castellani, Gastone; Zanoni, Michele; Cortesi, Michela; Vergani, Barbara; Leone, Biagio Eugenio; Righi, Simona; Gazzola, Anna; Casadei, Beatrice; Gentilini, Davide; Calzari, Luciano; Limarzi, Francesco; Sabattini, Elena; Pession, Andrea; Tazzari, Marcella; Bertuzzi, Clara | 2023-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | 0074_2023_IntJoMolecularSciences_Tumedei.pdf |
| Immunotherapy: The end of the "dark age" for metastatic triple-negative breast cancer? | Palleschi M.; Maltoni R.; Sarti S.; Melegari E.; Bravaccini S.; Rocca A. | 2020-01-01 | THE BREAST JOURNAL | - | 1.04 Replica / breve intervento (e simili) | - |
| Ki67 and PR in patients treated with CDK4/6 Inhibitors: A real-world experience | Palleschi M.; Maltoni R.; Ravaioli S.; Vagheggini A.; Mannozzi F.; Fanini F.; Pirini F.; Tumedei ...M.M.; Barzotti E.; Cecconetto L.; Sarti S.; Manunta S.; Possanzini P.; Fedeli A.; Curcio A.; Altini M.; de Giorgi U.; Rocca A.; Bravaccini S. | 2020-01-01 | DIAGNOSTICS | - | 1.01 Articolo in rivista | Ki67 and PR in Patients Treated with CDK4 6.pdf |
| NMR-Based Metabolomic Approach Tracks Potential Serum Biomarkers of Disease Progression in Patients with Type 2 Diabetes Mellitus | Del Coco, Laura; Vergara, Daniele; De Matteis, Serena; Mensà, Emanuela; Sabbatinelli, Jacopo; Pra...ttichizzo, Francesco; Bonfigli, Anna Rita; Storci, Gianluca; Bravaccini, Sara; Pirini, Francesca; Ragusa, Andrea; Casadei-Gardini, Andrea; Bonafè, Massimiliano; Maffia, Michele; Fanizzi, Francesco Paolo; Olivieri, Fabiola; Giudetti, Anna Maria | 2019-01-01 | JOURNAL OF CLINICAL MEDICINE | - | 1.01 Articolo in rivista | jcm-08-00720.pdf; jcm-08-00720-s001.pdf |
| Palbociclib (PD 0332991): Targeting the cell cycle machinery in breast cancer | Rocca A.; Farolfi A.; Bravaccini S.; Schirone A.; Amadori D. | 2014-01-01 | EXPERT OPINION ON PHARMACOTHERAPY | - | 1.03 Recensione in rivista | - |
| Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy | Rocca A.; Andreis D.; Fedeli A.; Maltoni R.; Sarti S.; Cecconetto L.; Pietri E.; Schirone A.; Bra...vaccini S.; Serra P.; Farolfi A.; Amadori D. | 2015-01-01 | EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | - | 1.03 Recensione in rivista | - |
| Progress with palbociclib in breast cancer: Latest evidence and clinical considerations | Rocca A.; Schirone A.; Maltoni R.; Bravaccini S.; Cecconetto L.; Farolfi A.; Bronte G.; Andreis D. | 2017-01-01 | THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | - | 1.03 Recensione in rivista | - |
| PSMA expression: A potential ally for the pathologist in prostate cancer diagnosis | Bravaccini S.; Puccetti M.; Bocchini M.; Ravaioli S.; Celli M.; Scarpi E.; De Giorgi U.; Tumedei ...M.M.; Raulli G.; Cardinale L.; Paganelli G. | 2018-01-01 | SCIENTIFIC REPORTS | - | 1.01 Articolo in rivista | - |
| Sorafenib for the treatment of breast cancer | Bronte G.; Andreis D.; Bravaccini S.; Maltoni R.; Cecconetto L.; Schirone A.; Farolfi A.; Fedeli ...A.; Serra P.; Donati C.; Amadori D.; Rocca A. | 2017-01-01 | EXPERT OPINION ON PHARMACOTHERAPY | - | 1.03 Recensione in rivista | - |
| T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer | Mazzotti, Lucia; Gaimari, Anna; Bravaccini, Sara; Maltoni, Roberta; Cerchione, Claudio; Juan, Man...el; Navarro, Europa Azucena-Gonzalez; Pasetto, Anna; Nascimento Silva, Daniela; Ancarani, Valentina; Sambri, Vittorio; Calabrò, Luana; Martinelli, Giovanni; Mazza, Massimiliano | 2022-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | ijms-23-08590-v2.pdf; ijms-23-08590-s001.zip |